Ensol Biosciences Inc. (XKON:140610)
8,600.00
-190.00 (-2.16%)
At close: Nov 5, 2026
| Market Cap | 123.64B -41.1% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 14.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,141 |
| Open | 8,800.00 |
| Previous Close | 8,790.00 |
| Day's Range | 8,200.00 - 8,970.00 |
| 52-Week Range | 7,750.00 - 17,900.00 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |